date:Jun 22, 2012
cleared the market of all DMAA (methylhexaneamine/1,3-dimethylamylamine)products while Sweden has taken action in Stockholm with other municipalities in the country set to follow.
We have been in contact with Denmark and Sweden and may also contact other agencies,said Mizahri, although she acknowledged the agency was not in possession of any adverse event reports.
not appropriate for human consumption
The Danish report (published October 2011) and Swedish report (May 2012) highlighted heart